Add to ORKGFas-mediated apoptosis: a novel therapeutic approach for acute T-cell leukemia. C ha p te r
DN T cells.DN T cell lymphoproliferation.The Fas pathway plays a critical role in regulating the tis...
Bone marrow failure is a condition that blocks normal hematopoiesis. Instead of producing functional...
leukemia (AML) cells express Fas recep-tor but are frequently resistant to Fas agonistic reagents. F...
Agonistic anti-Fas antibodies and multimeric recombinant Fas ligand (FasL) preparations show high tu...
Agonistic anti-Fas antibodies and multimeric recombinant Fas ligand (FasL) preparations show high tu...
Current treatment of human T-cell leukemia and lymphoma is predominantly limited to conventional cyt...
Expression of B7 on tumor cells can circumvent T cell tolerance and lead to the generation of tumor ...
The specific targeting of critical signaling molecules may provide efficient thera-pies for T-cell a...
Refractory T cell acute leukaemias that no longer respond to treatment would benefit from new modali...
The Fas antigen is a cell surface protein that can mediate apoptosis in a variety of cell types, inc...
The binding of soluble HLA class I (sHLA-I) molecules to CD8 on EBV-specific CTL induced up-regulati...
Clinical observation and laboratory evidence suggest that immune mechanisms play an important role i...
play key roles in apoptosis of cells of the immune system, function as effector molecules of cytotox...
Immunotherapy based on checkpoint inhibitors is providing substantial clinical benefit, but only to ...
Disruption of T cell regulatory pathways is necessary for immunotherapeutic cure of T cell acute lym...
DN T cells.DN T cell lymphoproliferation.The Fas pathway plays a critical role in regulating the tis...
Bone marrow failure is a condition that blocks normal hematopoiesis. Instead of producing functional...
leukemia (AML) cells express Fas recep-tor but are frequently resistant to Fas agonistic reagents. F...
Agonistic anti-Fas antibodies and multimeric recombinant Fas ligand (FasL) preparations show high tu...
Agonistic anti-Fas antibodies and multimeric recombinant Fas ligand (FasL) preparations show high tu...
Current treatment of human T-cell leukemia and lymphoma is predominantly limited to conventional cyt...
Expression of B7 on tumor cells can circumvent T cell tolerance and lead to the generation of tumor ...
The specific targeting of critical signaling molecules may provide efficient thera-pies for T-cell a...
Refractory T cell acute leukaemias that no longer respond to treatment would benefit from new modali...
The Fas antigen is a cell surface protein that can mediate apoptosis in a variety of cell types, inc...
The binding of soluble HLA class I (sHLA-I) molecules to CD8 on EBV-specific CTL induced up-regulati...
Clinical observation and laboratory evidence suggest that immune mechanisms play an important role i...
play key roles in apoptosis of cells of the immune system, function as effector molecules of cytotox...
Immunotherapy based on checkpoint inhibitors is providing substantial clinical benefit, but only to ...
Disruption of T cell regulatory pathways is necessary for immunotherapeutic cure of T cell acute lym...
DN T cells.DN T cell lymphoproliferation.The Fas pathway plays a critical role in regulating the tis...
Bone marrow failure is a condition that blocks normal hematopoiesis. Instead of producing functional...
leukemia (AML) cells express Fas recep-tor but are frequently resistant to Fas agonistic reagents. F...